Stroke
Patients taking one of the newer agents present with smaller, less severe hemorrhages, with potential gains in function and survival.
The analysis from SOCRATES is a “little methodologically shaky,” one expert says, but the hypothesis is worthy of study.…
The SPRINT analysis has no immediate therapeutic implications, since there are no good ways to reduce variability, one expert says.…
Resuming therapy was associated with lower risks of mortality and ischemic stroke and increased odds of a favorable functional outcome.…
Future trials should focus on patients with more severe strokes and use higher-intensity statin regimens, one expert says.…
Page 28 of 43